Oncolytic adenovirus co-expressing miRNA-34a and IL-24 induces superior antitumor activity in experimental tumor model. - Wikidata - awgldk - TriplyDB

Oncolytic adenovirus co-expressing miRNA-34a and IL-24 induces superior antitumor activity in experimental tumor model.

Oncolytic adenovirus co-expressing miRNA-34a and IL-24 induces superior antitumor activity in experimental tumor model.

http://www.wikidata.org/entity/Q39215780

about

Mechanism of Action and Applications of Interleukin 24 in Immunotherapy Managing Pancreatic Adenocarcinoma: A Special Focus in MicroRNA Gene Therapy siRNA Versus miRNA as Therapeutics for Gene Silencing Implications of biomarkers in human hepatocellular carcinoma pathogenesis and therapy Role of microRNAs in hepatocellular carcinoma: a clinical perspective Trial Watch:: Oncolytic viruses for cancer therapy Trial Watch-Oncolytic viruses and cancer therapy Regulation of glucose metabolism in hepatocarcinogenesis by microRNAs.The emerging and diverse roles of sirtuins in cancer: a clinical perspective.miR-34a: Multiple Opposing Targets and One Destiny in Hepatocellular Carcinoma.Mir-34: a new weapon against cancer?MiRNA regulation of TRAIL expression exerts selective cytotoxicity to prostate carcinoma cells.MiR-31 and miR-128 regulates poliovirus receptor-related 4 mediated measles virus infectivity in tumors.Cationic microRNA-delivering nanocarriers for efficient treatment of colon carcinoma in xenograft model.Fiber-modified hexon-chimeric oncolytic adenovirus targeting cancer associated fibroblasts inhibits tumor growth in gastric carcinoma.Simultaneous overexpression of miR-126 and miR-34a induces a superior antitumor efficacy in pancreatic adenocarcinoma.Therapeutic targeting of non-coding RNAs in cancer.MicroRNA regulation of K-Ras in pancreatic cancer and opportunities for therapeutic intervention.Antitumour activity of an inhibitor of miR-34a in liver cancer with β-catenin-mutations.MicroRNA-34a expression is predictive of recurrence after radiofrequency ablation in early hepatocellular carcinoma.Oncolytic virotherapy in upper gastrointestinal tract cancers.

P2860

Q26748450-71D0E922-CC17-42A4-BC69-CD1F124D3817 Q26749037-6972131B-C064-4909-AE40-99FD87DA0CFE Q26786876-DB06C38D-B9EA-4950-BCDE-B289E4C141A0 Q27005850-7F07E4BC-9B46-4AD7-89A5-7EBE9803145C Q27014034-F666719C-50E8-449D-9A0A-54D40FD42F0C Q27021951-4268F75C-6220-4061-8CF9-C2A56E763FD6 Q28072347-1D96CE69-C01A-4351-8F39-057947B129C9 Q34803043-AAF89DB7-C86C-4006-92CD-84C49F81F1F0 Q37231067-D789CFEB-BA7E-407C-BE14-4AD0232DCED2 Q37578281-382B358B-6301-4F42-8909-15D3303D5DD4 Q38253374-E7FF4449-19BD-43EF-91A5-A6ADCEB8D52D Q39051553-3A1AD5D8-09B7-45BB-9F1B-F9948D5BDD47 Q40581942-263E1A42-E969-4450-B914-3FF390D91F8D Q42048438-302E894A-7B24-4382-9CC9-9FAA64D9E594 Q46633886-B1EF0253-A164-4FA0-8353-647598C5D02E Q47122468-EE7143BE-D47B-4C64-9BF4-05C9FF5AEA0C Q47292099-E726EAAE-C477-4757-ACE9-A692E51F8AD6 Q49335684-FF588287-4F7F-42E9-B7E3-96C9BF9D98B2 Q50997346-B93D41F8-CF8E-4CF5-8E9E-756576A65962 Q53642072-8AF6C050-CC2C-4F6F-B2F4-8D18F5EB3256 Q54242367-C6A0F449-4755-4DCD-BE9D-E1FECB111162

P2860

Oncolytic adenovirus co-expressing miRNA-34a and IL-24 induces superior antitumor activity in experimental tumor model.

http://www.wikidata.org/entity/Q39215780

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh

2013年學術文章

@zh-hant

name

Oncolytic adenovirus co-expres ...... y in experimental tumor model.

@en

Oncolytic adenovirus co-expres ...... y in experimental tumor model.

@nl

type

label

Oncolytic adenovirus co-expres ...... y in experimental tumor model.

@en

Oncolytic adenovirus co-expres ...... y in experimental tumor model.

@nl

prefLabel

Oncolytic adenovirus co-expres ...... y in experimental tumor model.

@en

Oncolytic adenovirus co-expres ...... y in experimental tumor model.

@nl

P1433

Q39215780-4407E135-A404-46E5-BEC9-0186E2FBB00B

P1476

Q39215780-7FEC1A00-5B12-4ECC-A6BC-62057CCE23C1

P2093

Q39215780-1622AE59-9FA4-41DB-8B1D-5D8172A74B62

Q39215780-29583A8B-14A8-4FF9-AC13-045370C02FEA

Q39215780-3CD93244-4C88-4820-96BD-4660BB8DF3A9

Q39215780-4142825B-1BD9-4CDB-94C1-9E6CC4389305

Q39215780-4574463B-944E-48C8-93C1-42420B265AD4

Q39215780-4D7A82B5-B5E1-4B2D-8CE6-4D3E74E7CC6F

Q39215780-6DFBE6D6-93C3-4E4C-B95B-9B55E975F3C2

Q39215780-7B4A1D54-9E1E-4C4E-8E9F-601CB18029CA

Q39215780-9BBD2C58-3C97-4787-90C3-60527B789294

P2860

Q39215780-024F2BB3-1A22-4C67-8CCF-64AAD57DC1C1

Q39215780-0DD60CD3-25FA-48AA-B4EC-5D75107BC038

Q39215780-1638D621-C9FB-4D13-9139-1FACB63F280D

Q39215780-1B66B6E3-BE0E-45EB-B6A5-55BC7124DC56

Q39215780-1EE92558-E961-4010-828C-B058F9611129

Q39215780-2343A859-BBA9-4982-A1FE-7DD09578593C

Q39215780-32EAA5A8-30D9-4265-8C0B-EE334C39F377

Q39215780-5DFE00E5-F5CE-49A3-B789-99F011CBA48C

Q39215780-604593C6-E7C7-4A27-8872-06D36A5DA8A4

Q39215780-679EE3FF-5AA8-468A-A9D7-6FB4A7A61425

P2888

Q39215780-358C0B96-F815-490E-9990-10D9EC2C6B9C

P304

Q39215780-692A5018-3B0E-4DB4-95FF-8E451B574E6D

P31

Q39215780-939A8396-6884-4D08-B028-B72C6B7A18F1

P356

Q39215780-FA5F07C3-1049-4C44-9BAB-788F7C770CAA

P433

Q39215780-EA5D186D-EE6D-47B5-97FF-CB760BF47659

P478

Q39215780-402B0AD3-9CC1-48E6-9A79-87B9087EFC45

P577

Q39215780-51215B8E-DF02-4616-BE14-B93F86A5B1ED

P5875

Q39215780-4E90526F-DD9A-4E48-8238-034320E8204E

P698

Q39215780-EA0737BA-A575-46F4-8607-0DAD362C5022

P921

Q39215780-193CFC53-E4B3-4D88-958B-8C8B3498A7BB

Q39215780-E17A4DF9-506F-4A9C-8C03-872FBE8CD57F

P356

S00109-012-0985-X

P1433

Journal of Molecular Medicine

P1476

Oncolytic adenovirus co-expres ...... y in experimental tumor model.

@en

P2093

Cheng Qian

http://www.w3.org/2001/XMLSchema#string

Jia Liu

http://www.w3.org/2001/XMLSchema#string

Junjie Shen

http://www.w3.org/2001/XMLSchema#string

Leina Ma

http://www.w3.org/2001/XMLSchema#string

Qing Chen

http://www.w3.org/2001/XMLSchema#string

Wenjia Lou

http://www.w3.org/2001/XMLSchema#string

Xiu-Wu Bian

http://www.w3.org/2001/XMLSchema#string

Youhong Cui

http://www.w3.org/2001/XMLSchema#string

Zhi Yang

http://www.w3.org/2001/XMLSchema#string

P2860

The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44

MicroRNAs and metastasis: little RNAs go a long way

miR-34a repression of SIRT1 regulates apoptosis

Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model

Identification of microRNA-181 by genome-wide screening as a critical player in EpCAM-positive hepatic cancer stem cells

A simplified system for generating recombinant adenoviruses

Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells

MiR-199a-3p regulates mTOR and c-Met to influence the doxorubicin sensitivity of human hepatocarcinoma cells

Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis

microRNAs join the p53 network--another piece in the tumour-suppression puzzle.

P2888

s00109-012-0985-x

P304

715-725

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00109-012-0985-X

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

91

http://www.w3.org/2001/XMLSchema#string

P577

2013-01-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

234069875

http://www.w3.org/2001/XMLSchema#string

P698

23292172

http://www.w3.org/2001/XMLSchema#string

P921

oncolytic virus